The launch of ‘ChatGPT for health’ is both a threat and an opportunity
OpenAI’s entry into consumer health is not speculative innovation but a response to behaviour already happening at scale. For the NHS, it exposes a long-ignored gap in law, interoperability and patient agency that policy can no longer sidestep
Register with hsj.co.uk to read the rest of this article
Critical stories remain free for registered users
Certain articles and Insight pieces remain paying-subscriber only content
As a registered user you will get access to:
- Daily News: an essential email round-up of all the latest news, comment and best practice
- Breaking news headlines delivered directly to your inbox
- Limited access to hsj.co.uk
Already registered to HSJ? Sign in now